113 related articles for article (PubMed ID: 17635241)
1. Biphenotypic bigenotypic lymphoma with simultaneous expression of PAX5/BSAP and B- and T-cell markers.
Hansson M; Jerkeman M; Dictor M
Eur J Haematol; 2007 Aug; 79(2):159-65. PubMed ID: 17635241
[TBL] [Abstract][Full Text] [Related]
2. An unusual case of biphenotypic, bigenotypic mature lymphoma.
Koletsa T; Kotoula V; Christoforidou A; Pantelidou P; Petrakis G; Tsatalas C; Kostopoulos I
J Clin Pathol; 2013 Dec; 66(12):1090-2. PubMed ID: 23794479
[No Abstract] [Full Text] [Related]
3. Diagnostic uses of Pax5 immunohistochemistry.
Feldman AL; Dogan A
Adv Anat Pathol; 2007 Sep; 14(5):323-34. PubMed ID: 17717432
[TBL] [Abstract][Full Text] [Related]
4. High-Grade Epstein-Barr Virus-Negative Biphenotypic Lymphoma with Expression of B- and T-Cell Markers and Leukemia Presentation: Case Report and Literature Review.
Kohla S; Ibrahim FA; Mudawi D; Akiki S; Soliman D; Al-Sabbagh A; Youssef RRH; Yassin MA
Case Rep Oncol; 2020; 13(3):1215-1226. PubMed ID: 33173488
[TBL] [Abstract][Full Text] [Related]
5. Isoforms of Pax5 and co-regulation of T- and B-cells associated genes influence phenotypic traits of ascetic cells causing Dalton's lymphoma.
Bharti B; Mishra R
Biochim Biophys Acta; 2011 Dec; 1813(12):2071-8. PubMed ID: 21854813
[TBL] [Abstract][Full Text] [Related]
6. B cell activator PAX5 promotes lymphomagenesis through stimulation of B cell receptor signaling.
Cozma D; Yu D; Hodawadekar S; Azvolinsky A; Grande S; Tobias JW; Metzgar MH; Paterson J; Erikson J; Marafioti T; Monroe JG; Atchison ML; Thomas-Tikhonenko A
J Clin Invest; 2007 Sep; 117(9):2602-10. PubMed ID: 17717600
[TBL] [Abstract][Full Text] [Related]
7. Rare lymphoid neoplasms coexpressing B- and T-cell antigens. The role of PAX-5 gene methylation in their pathogenesis.
Lazzi S; Bellan C; Onnis A; De Falco G; Sayed S; Kostopoulos I; Onorati M; D'Amuri A; Santopietro R; Vindigni C; Fabbri A; Righi S; Pileri S; Tosi P; Leoncini L
Hum Pathol; 2009 Sep; 40(9):1252-61. PubMed ID: 19368954
[TBL] [Abstract][Full Text] [Related]
8. [Analyses of the rearrangement of T-cell receptor- and immunoglobulin genes in the diagnosis of lymphoproliferative disorders].
Griesser DH
Veroff Pathol; 1995; 144():1-109. PubMed ID: 7856305
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Pax5 expression and comparison with BLA.36 and CD79αcy in feline non-Hodgkin lymphoma.
Felisberto R; Matos J; Alves M; Cabeçadas J; Henriques J
Vet Comp Oncol; 2017 Dec; 15(4):1257-1268. PubMed ID: 27549353
[TBL] [Abstract][Full Text] [Related]
10. Single cell origin of bigenotypic and biphenotypic B cell proliferations in human follicular lymphomas.
Cleary ML; Galili N; Trela M; Levy R; Sklar J
J Exp Med; 1988 Feb; 167(2):582-97. PubMed ID: 3126254
[TBL] [Abstract][Full Text] [Related]
11. Lineage differentiation of canine lymphoma/leukemias and aberrant expression of CD molecules.
Wilkerson MJ; Dolce K; Koopman T; Shuman W; Chun R; Garrett L; Barber L; Avery A
Vet Immunol Immunopathol; 2005 Jul; 106(3-4):179-96. PubMed ID: 15963817
[TBL] [Abstract][Full Text] [Related]
12. [Expression of B cell-specific activator protein in lymphomas].
Li D; Li GD; Liu WP; Li FY; Zhang WY; Liao DY
Zhonghua Bing Li Xue Za Zhi; 2005 Jun; 34(6):345-7. PubMed ID: 16185503
[TBL] [Abstract][Full Text] [Related]
13. Immunophenotypic and antigen receptor gene rearrangement analysis in T cell neoplasia.
Knowles DM
Am J Pathol; 1989 Apr; 134(4):761-85. PubMed ID: 2495724
[TBL] [Abstract][Full Text] [Related]
14. Expression of B cell-associated transcription factors in B-cell precursor acute lymphoblastic leukemia cells: association with PU.1 expression, phenotype, and immunogenotype.
Nishii K; Kita K; Miwa H; Shikami M; Taniguchi M; Usui E; Katayama N; Shiku H
Int J Hematol; 2000 Jun; 71(4):372-8. PubMed ID: 10905058
[TBL] [Abstract][Full Text] [Related]
15. Combined analysis of T cell receptor gamma and immunoglobulin heavy chain gene rearrangements at the single-cell level in lymphomas with dual genotype.
Vergier B; Dubus P; Kutschmar A; Parrens M; Ferrer J; de Mascarel A; Merlio JP
J Pathol; 2002 Oct; 198(2):171-80. PubMed ID: 12237876
[TBL] [Abstract][Full Text] [Related]
16. Conversion of mature B cells into T cells by dedifferentiation to uncommitted progenitors.
Cobaleda C; Jochum W; Busslinger M
Nature; 2007 Sep; 449(7161):473-7. PubMed ID: 17851532
[TBL] [Abstract][Full Text] [Related]
17. PAX8 and PAX5 are differentially expressed in B-cell and T-cell lymphomas.
Morgan EA; Pozdnyakova O; Nascimento AF; Hirsch MS
Histopathology; 2013 Feb; 62(3):406-13. PubMed ID: 23163626
[TBL] [Abstract][Full Text] [Related]
18. Pax5 immunostaining in paraffin-embedded sections of canine non-Hodgkin lymphoma: a novel canine pan pre-B- and B-cell marker.
Willmann M; Müllauer L; Guija de Arespacochaga A; Reifinger M; Mosberger I; Thalhammer JG
Vet Immunol Immunopathol; 2009 Apr; 128(4):359-65. PubMed ID: 19100628
[TBL] [Abstract][Full Text] [Related]
19. CD30 Expression by B and T Cells: A Frequent Finding in Angioimmunoblastic T-Cell Lymphoma and Peripheral T-Cell Lymphoma-Not Otherwise Specified.
Onaindia A; Martínez N; Montes-Moreno S; Almaraz C; Rodríguez-Pinilla SM; Cereceda L; Revert JB; Ortega C; Tardio A; González L; García S; Camacho FI; González-Vela C; Piris MA
Am J Surg Pathol; 2016 Mar; 40(3):378-85. PubMed ID: 26574847
[TBL] [Abstract][Full Text] [Related]
20. Expression of B cell-specific activator protein/PAX5 in acute myeloid leukemia with t(8;21)(q22;q22).
Valbuena JR; Medeiros LJ; Rassidakis GZ; Hao S; Wu CD; Chen L; Lin P
Am J Clin Pathol; 2006 Aug; 126(2):235-40. PubMed ID: 16891199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
